Riverview Trust Company’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-78
| Closed | -$21.1K | – | 241 |
|
|
2025
Q1 | $21.1K | Hold |
78
| – | – | 0.02% | 411 |
|
|
2024
Q4 | $18.4K | Buy |
78
+75
| +2,500% | +$17.6K | 0.02% | 505 |
|
|
2024
Q3 | $825 | Buy |
+3
| New | +$825 | ﹤0.01% | 671 |
|
|
2024
Q2 | – | Sell |
-104
| Closed | -$15.5K | – | 627 |
|
|
2024
Q1 | $15.5K | Buy |
+104
| New | +$15.5K | 0.01% | 583 |
|
|
2023
Q3 | – | Sell |
-67
| Closed | -$12.7K | – | 678 |
|
|
2023
Q2 | $12.7K | Buy |
+67
| New | +$12.7K | 0.01% | 641 |
|
|
2022
Q2 | – | Sell |
-94
| Closed | -$15K | – | 711 |
|
|
2022
Q1 | $15K | Buy |
+94
| New | +$15K | 0.01% | 598 |
|